Literature DB >> 26040096

The level of improvement of visual acuity in high corneal astigmatism with rigid gas permeable contact lenses.

Dalibor Opačić, Snježana Miljak, Ksenija Ćuruvija-Opačić.   

Abstract

The aim of this study was to calculate the level of improvement of visual acuity comparing the best corrected visual acuity (VA) achieved with spectacles with the best corrected VA achieved with rigid gas permeable (RGP) contact lenses in patients with high, simple or compound corneal astigmatism (myopic, hypermetropic and mixed). The investigation of patients included auto-kerato-refractometry, manual keratometry, corneal topography and visual acuity with Snellen chart. The best corrected VA obtained with spectacles was compared with the best corrected VA obtained with RGP contact lenses in 72 patients (116 eyes). All patients showed a significant improvement in visual acuity with RGP lenses from one to seven lines compared to spectacles (p = 0.0001). Level of improvement in VA represented as the number of lines obtained was as follows: 74 percent of patients got two to four lines more in VA with RGP lenses compared to spectacles, and almost 10 percent of patients got five to seven lines. RGP contact lenses provide a significant improvement in VA compared to VA reached with spectacles in patients with high corneal astigmatism. The benefit in VA with RGP lenses is higher as the astigmatism is higher.

Entities:  

Mesh:

Year:  2015        PMID: 26040096

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  2 in total

1.  Visual Acuity and Refractive Error Improvement in Keratoconic Patients: A Low-Income Context Management Perspective.

Authors:  Walter Kibet Yego; Vanessa Raquel Moodley
Journal:  Clin Optom (Auckl)       Date:  2020-08-19

2.  Fitting Tips and Visual Rehabilitation of Irregular Cornea with a New Design of Corneoscleral Contact Lens: Objective and Subjective Evaluation.

Authors:  Waleed Ali Abou Samra; Amani E Badawi; Hanem Kishk; Ayman Abd El Ghafar; Mohamed M Elwan; Hossam Youssef Abouelkheir
Journal:  J Ophthalmol       Date:  2018-02-01       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.